Paeoniflorin

also known as NSC-178886 · PAE · Peoniflorin

today NCT02878863 · Ph 3

2017201820192020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT02878863	Aug 2016 → Mar 2017	autoimmune hepatitis	Xiaoli Fan	Withdrawn	No outcome recorded

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT01600521 Comparator	Nov 2004 → Apr 2011	rheumatoid arthritis	University of Minnesota	Completed	No outcome recorded

Every value below carries the sentence it was read from. 3 sources stand behind the page.

Field	Value	Cited text
Known as	Paeoniflorin	“Paeoniflorin (PAE), the extract from peony (Paeonia lactiflora), is an active ingredient with anti-inflammation properties.” NCT01600521 ↗ 1 NCT02878863 ↗
Known as	NSC-178886	ChEMBL registry synonym — accepted as the source's own label CHEMBL4303209 ↗
Known as	PAE	“Paeoniflorin (PAE), the extract from peony (Paeonia lactiflora), is an active ingredient with anti-inflammation properties.” NCT01600521 ↗
Known as	Peoniflorin	ChEMBL registry synonym — accepted as the source's own label CHEMBL4303209 ↗
Modality	Small molecule	— CHEMBL4303209 ↗
Route	Oral	“PAE was administrated orally 600 mg twice a day for at least 12 months.” NCT01600521 ↗